Multiple drug makers defeat thousands of lawsuits on Zantac cancer claims
The companies involved who marketed the drug still face tens of thousands of other lawsuits in U.S. states, but the latest judgements remove much of their liability.
Stay updated with breaking news from Robin Rosenberg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The companies involved who marketed the drug still face tens of thousands of other lawsuits in U.S. states, but the latest judgements remove much of their liability.
LONDON/PARIS (Reuters) - Shares of GSK and Sanofi surged in early trading on Wednesday, following the dismissal of thousands of U.S. lawsuits claiming...
Shares of GSK and Sanofi surged on Wednesday, adding more than $20 billion in combined value in early trade following the dismissal of thousands of U.S.
GSK shares jumped today after the pharmaceutical group, along with Pfizer and Sanofi SA successfully defeated thousands of lawsuits alleging the heartburn drug Zantac caused cancer.
Shares of GSK and Sanofi surged on Wednesday, adding more than $20 billion in combined value in early trade following the dismissal of thousands of U.S. lawsuits claiming that the heartburn drug Zantac caused cancer.